BIONIME was founded in April 2003 and is specialized in the biotechnology and medical testing business. The first line of products is the Blood Glucose Self Monitoring (SMBG) system. BIONIME integrates top-level expertise in medical science, chemistry, electronics, and precision mechanisms to market unique test strip structure patented technology. BIONIME currently operates four subsidiaries in major markets, Europe, America, and China. Our products have been highly recognized internationally and successfully distributed in the worldwide markets through outstanding clinical tests and well-known journals. With the support of our customers, we are confident that BIONIME will grow the SMBG (Self-Monitor Blood Glucose) global competitive leadership.